Longitudinal studies in the prevention of cardiovascular diseases;Los estudios longitudinales en la prevención de las enfermedades cardiovasculares

Revista Espanola de Salud Publica

Volumn 78, Issue 2, 2004, Pages 149-166

  Balaguer Vintró, Ignacio ^a,b  

^a Hospital Sant Pau   (Spain)

^b NONE   (Spain)

Author keywords

Body mass index; Cardiovascular diseases; Cholesterol; Cohort studies; Coronary heart disease; Hypertension; Ischaemic heart disease; Longitudinal studies; Mortality; Myocardial infarction; Prevention; Risk factors; Tobacco

Indexed keywords

CHOLESTEROL;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK MANAGEMENT; SMOKING; SYSTEMATIC REVIEW;

EID: 2442713540     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1135-57272004000200003     Document Type: Review

References (65)

1. Gertler MM, White PD. Coronary Heart Disease in Young Adults. A Multidisciplinary Study. Cambridge Mass: Harvard Medical Press; 1954.
2. Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JT, Simonson E. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation 1963; 28: 381-95.
3. Dawber TR. The Framingham Study. The Epidemiology of Atherosclerosis Disease. Cambridge Mas. Londres: Harvard University Press; 1980.
4. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events. Final report of the Pooling Project. J Chron Dis 1978; 31: 201-306.
5. Epstein FH, Ostrander LD, Johnson BC, Payne MW, Hayner NS, Keller JB, Francis T. Epidemiological studies of cardiovascular disease in a total community - Tecumseh, Michigan. Ann Intern Med 1965; 62: 1170-88.
6. Rosenman RH, Brand RJ, Jenkins D, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study. Final Follow-up experience of 8 1/2 years. JAMA 1975; 233: 872-7.
7. Ragland DR, Brand RJ. Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidem 1988; 127: 462-75.
8. Garcia-Palmieri M, Sorlie PD, Havlik RJ, Costas R, Cruz-Vidal M. Urban-rural differences in 12 year coronary heart disease mortality: the Puerto Rico Heart Health Program. J Clin Epidemiol 1988; 41: 285-92.
9. Kleinbaum DG, Kupper LL, Cassel JC, Tyroler HA. Multivariate analysis of risk of coronary heart disease in Evans County, Georgia. Arch Intern Med 1971; 128: 943-48.
10. Pell S, Fayerweather WF. Trends in the incidence of myocardial infarction and in the associated mortality and morbidity in a large employed population: 1957-1983. J Engl J Med 1985; 312: 1005-11.
11. Yano K, MacLean ChJ, Reed DM, Shimizu Y, Sasaki H, Kodama K, Kato H, Kagan A. A comparison of the 12-year mortality and predictive factors of coronary heart disease among japanese men in Japan and Hawaii. Am J Epidem 1988; 127: 476-87.
12. Paffenbarger RS Jr, Laughlin ME, Gima AS, Black RA. Work activity of longshoremen as related to death from coronary heart disease and stroke. N Engl J Med 1970; 282: 1109-13.
13. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in collegi alumni. Am J Epidemiol 1987; 108: 161-75.
14. Croft JB, Webber LS, Parker FC, Berenson GS. Recruitment and participation of children in a long-term study of cardiovascular disease: the Bogulasa Heart Study. Am J Epidemiol 1984; 120: 436-48.
15. Friedman G, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, Liu K, Savage PJ. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-16.
16. Kimura N. Análisis de 10.000 autopsias en el Japón. En Tendencias Mundiales en Cardiología. Madrid: Alhambra; 1958.p.25-35.
17. The Seven Countries Study. A scientific adventure in cardiovascular disease epidemiology. Ed por D Kromhout, A Menotti, H Blackburn. Utrecht: Brouwer Offset; 1993.
18. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41 (Suppl I): 1-211.
19. Keys A. Seven Countries. A multivariate analysis of death and coronary heart disease. Cambridge and London, A Commonwealth Fund Book. Harvard University Press; 1980.
20. Keys A, Menotti A, Karvonen MJ, Aravanis Ch, Blackburn H, Buzina R et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986; 124: 903-15.
21. Menotti A, Conti S. Giampaoli S, Mariotti S, Signoretti P. Coronary risk factors predicting coronary and other causes of death in fifteen years. Acta Cardiológica 1980; 35: 107-120
22. Kromhout D, Nissinen A, Menotti A, Bloembeg B, Pekkanen J, Giampaoli S. Total and HDL cholesterol and their correlates in elderly men in Finland, Italy and the Netherlands. Am J Epidemiol 1990; 131: 855-63.
23. Menotti A, Keys A, Kromhout D, Blackburn H, Aravanis Ch, Bloemberg B, Buzina R, Dontas A, Fidanza F, Giampaoli S, Karvonen M, Lanti M, Mohacek I, Nedeljkovic S, Nissinen A, Pekkanen J, Punsar S, Seccareccia F, Toshima H, Intercohort differences in coronary heart disease mortality in the 25-year follow-up of the Seven Countries Study. Eur J Epidemiol 1993; 9: 527-36.
24. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; i: 1017-20.
25. Lessons for Science from the Seven Countries Study. A 35-year collaborative experience in cardiovascular disease epidemiology. H Toshima, Y Koga, H Blackburn, A Keys ed. Tokyo: Springer-Verlag; 1994.
26. Carlson LA, Böttiger LE. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockolm Prospective Study. Acta Med Scand 1985; 218: 207-11.
27. Welin J, Larsson R, Svandsudd N, Wilhelmsen L, Tibblin G. Why the incidence of ischaemic heart disease in Sweden is increasing? Study of men born in 1913 and 1923. Lancet 1983; i: 1087-89.
28. Preventive Cardiology, Ed. Gösta Tibblin, Ancel Keys, Lars Werkö. Stockholm: Almqvist & Wiksell; 1972.
29. Johansson S, Wilhelmsen L, Lappas G, Rosengren A. High lipid levels and coronary disease in women in Goteborg - outcomes and secular trends: a prospective 19 year follow-up in the BEDA study. Eur Heart J 2003; 24: 704-16.
30. Rose G, Reid DD, Hamilton PJS, McCartney P, Keen H, Jarrett RJ. Myocardial ischaemia, risk factors and death from coronary heart disease. Lancet 1977; i: 105-09.
31. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. Geneva: World Health Organization; 1982.
32. Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J 1986; 293: 306-7.
33. Tomás Abadal L, Balaguer Vintró I, Bernades Bernat E. Factores de riesgo e incidencia de nuevos casos en el estudio prospectivo de la cardiopatia isquemica de Manresa. Rev Esp Cardiol 1976; 29: 127-35.
34. Tomás Abadal L, Varas Lorenzo C, Bernades Bernat E, Balaguer Vintró I. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a mediterranean industrial population. The Manresa Study, Spain. Eur Heart J 1994; 15: 1028-36.
35. Tomás Abadal L, Puig T, Balaguer Vintró I. Accidente vascular cerebral: incidencia, mortalidad y factores de riesgo en 28 años de seguimiento. Estudio de Manresa. Rev Esp Cardiol 2000; 53: 15-20.
36. Tomás Abadal L, Varas Lorenzo C, Pérez I, Puig T, Balaguer Vintró I. Factores de riesgo y morbimortalidad coronaria en una cohorte laboral mediterránea seguida durante 28 años. Estudio de Manresa. Rev Esp Cardiol 2001; 54: 1146-54.
37. Ducimetiere P, Richard JL, Combien F, Rakotovao R, Claude JR. Coronary heart disease in middle-aged frenchman. Comparison between Paris Prospective Study, Seven Countries Study and Pooling Project. Lancet 1980; i: 1346-50.
38. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thompson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J 1981; 283: 179-86.
39. Shaper AG, Pocock SJ, Walker M, Phillips AN, Whitehead TP, Macfarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985; 39: 197-209.
40. Emberson JR, Whincup PH, Morris RW, Walker M. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J 2003; 24: 1719-26.
41. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principals results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
42. Yarnell JWG, Baker IA, Sweetman PM, Bainton D, O'Brien JR, Whitehead PhJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Study. Circulation 1991; 83: 836-44.
43. Hense HW, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 24: 937-45.
44. Feinleib M, Garrison RJ, Stallones L, Kannel WB, Castelli WP, McNamara PM. A comparison of blood pressure, cholesterol and cigarette smoking in parents in 1950 and children in 1970, Am J Epidemiol 1979; 110: 291-303.
45. Camargo CA, Hennekens ChH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med 1997; 157: 79-85.
46. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, Willett WC. Vitamin C and risk of coronary heart disease in women. J Am Coll Med 2003; 42: 246-52.
47. Khaw KT, Barrett-Connor E. Dietary fiber and reduced ischaemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol 1987; 126: 1093-102.
48. Kromhout D, Bosschieter EB. Coulander DC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl j Med 1985; 312: 1205-09.
49. Masiá R, Peña A, Marrugat J, Sala J, Vila J, Pavesi M, Covar M, Aubó C, Elosua R and the REGICOR investigators. High prevalence of cardiovascular risk factors in Girona, Spain a province with low myocardial infarction incidence. J Epidemiol Community Health 1998; 52: 707-15.
50. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Shervin R, Shih, Stamler J, Wentworth D. Serum cholesterol level and mortality findings in men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992; 152: 1490-500.
51. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland Ph. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings of 5 large cohorts of young adulta and middle-aged men and women. JAMA 1999; 282: 2012-18.
52. Rose G, Heller RF, Tunstall Pedoe H, Christe DGS. Heart disease prevention project: a randomised controlled trial in industry. Br Med J 1989; i: 747-51.
53. Tunstall Pedoe H, Sans Menéndez S, Balaguer Vintró I, en nombre del Grupo Colaborativo Europeo de la OMS. Cambios en los factores de riesgo coronario durante 6 años de intervención en el Ensayo Multifactorial Colaborativo de la Organización Mundial de la Salud. Rev Esp Cardiol 1989: 42, supl 1: 3-16.
54. WHO European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on a 6-year results. Lancet 1986; i: 869-72.
55. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werkö L. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986; 7: 279-88.
56. MONICA: Monograph and Multimedia Source Book. World's largest study of heart disease, stroke, risk factors and populations trends (1979-2002). Ed Hugh Tunstall-Pedoe. Geneva: World Health Organization; 2003.
57. Yusuf S, Reddy S, Ôunpu S, Anand S. Global burden of cardiovascular diseases. II Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855-64.
58. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmamm SP, Goff D, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee, World Heart Federation Council on Epidemiology and Prevention; The European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Hearth, Lung and Blood Institute. Circulation 2003; 108: 2543-49.
59. Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000; 320: 676-7.
60. Menotti A, Puddu PE, Lanti P. Comparison of the Framingham risk function-based coronary chart with risk function from an italian study. Eur Heart J 2000; 21: 365-70.
61. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, DeBacker G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE Project. Eur Heart J 2003; 24: 987-1003.
62. DeBacquer G, Ambrosioni E, Borch-Johensen K, Brotons C, Dallongeville J, Ebrahim S, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur Heart J 2003; 24: 1601-10.
63. Balaguer Vintró I. Epidemiología de la cardiopatía isquémica. Avances y controversias. En Cardiopatía isquémica. Ed por P Zarco. Madrid: Clínicas Médicas de España, Editorial Médica Panamericana; 2000. p. 23-42.
64. Kannel WB. Contribution of Framingham Study to the conquest of coronary heart disease. Am J Cardiol 1988; 62: 109-12.
65. Wilhelmsen L, Svardsudd K, Korsand-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl j Med 1984; 311: 501-5.